TokenPost topic

REVB

1 TokenPost story is tagged REVB. The newest appear first.

Latest REVB stories

• Revelation Biosciences Posts $5.92 GAAP Loss Per Share in Q3 2026

  Cash and cash equivalents were $9.1 million on Sept. 30, 2026, compared with $10.7 million on Dec. 31, 2025.

  Nov 7, 2026, 8:51 PM EST · Business